dr. oh on results of chemotherapy versus arta in prostate cancer
Published 7 years ago • 196 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:02
dr. oh discusses the role of chemotherapy in prostate cancer
-
1:02
dr. oh on choosing ar-targeted therapy versus chemotherapy in mhspc
-
1:26
dr. oh discusses choosing abiraterone in prostate cancer
-
1:47
dr. oh on remaining challenges with docetaxel in prostate cancer
-
1:17
dr. oh on the safety profile of docetaxel in prostate cancer
-
1:12
dr. oh on the management of hormone-sensitive prostate cancer
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
0:53
dr. oh on the sequencing of new therapies for prostate cancer
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
1:36
dr. oh on ar-targeted therapy and chemotherapy for crpc
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
1:00
dr. abida on future of hormonal therapy in prostate cancer
-
2:09
dr. oh on the enzamet trial in mhspc
-
1:00
dr. wise on ar-directed therapy for prostate cancer
-
4:22
fatigue in men with castration resistant prostate cancer treated with enzalutamide
-
1:23
dr. morris on safety profiles of ar inhibitors in prostate cancer
-
1:11
dr. oh on immunotherapies for prostate cancer
-
1:31
dr. abida on choosing between chemotherapy and targeted agents for patients with prostate cancer